What does Cyclacel Pharmaceuticals, Inc. do?

Jun 22 2025 06:35 PM IST
share
Share Via
Cyclacel Pharmaceuticals, Inc. develops anticancer drugs based on cell cycle biology and has a market cap of $7.80 million. The company reported no net profit recently and has a dividend yield of 24.30%.
Overview:
Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology within the Pharmaceuticals & Biotechnology industry, focusing on the development of anticancer drugs.

Financial Snapshot:
- Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025)
- Market-cap: USD 7.80 Million (Micro Cap)

Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 24.30%
- Debt Equity: -1.13
- Return on Equity: -272.53%
- Price to Book: 2.55

Contact Details:
- Address: 200 Connell Dr Ste 1500, BERKELEY HEIGHTS NJ: 07922-2811
- Tel: 1 908 5177330
- Fax: 1 866 2713466
- Website: http://www.cyclacel.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Cyclacel Pharmaceuticals, Inc.?
Jun 22 2025 05:56 PM IST
share
Share Via